Their inhibition can be potentially explorable in PEL therapy, considering that a cross-talk between these pathways and other prosurvival pathways, such as NF-κB and PI3K/AKT/m-TOR, has been reported [30]. Here, AKT1 is linked to primary effusion lymphoma.